Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Kearon

Showing results (71-80 of 152) with videos related to

Pageof 16
Sort By:
Annals of Internal Medicine|May 19, 2010
The vexing problem of guidelines and conflict of interest: a potential solutionGordon Guyatt, Elie A Akl, Jack Hirsh, et al.
The American Journal of Emergency Medicine|August 6, 2018
Comparison of the age-adjusted and clinical probability-adjusted D-dimer to exclude pulmonary embolism in the EDSameer Sharif, Michelle Eventov, Clive Kearon, et al.
Journal of Thrombosis and Haemostasis : JTH|September 26, 2021
Statins for venous event reduction in patients with venous thromboembolism: A multicenter randomized controlled pilot trial assessing feasibilityAurélien Delluc, Waleed Ghanima, Michael J Kovacs, et al.
The Lancet. Neurology|August 18, 2006
Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational studyMartin O'Donnell, Wes Oczkowski, Jiming Fang, et al.
Thrombosis Research|March 28, 2022
Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER)Aurélien Delluc, Waleed Ghanima, Michael J Kovacs, et al.
The New England Journal of Medicine|February 22, 2013
Extended use of dabigatran, warfarin, or placebo in venous thromboembolismSam Schulman, Clive Kearon, Ajay K Kakkar, et al.
Thrombosis and Haemostasis|September 26, 2015
Bleeding events with dabigatran or warfarin in patients with venous thromboembolismAmmar Majeed, Samuel Z Goldhaber, Ajay Kakkar, et al.
Chest|July 14, 2009
Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolismFrancis Couturaud, Christophe Leroyer, Jim A Julian, et al.
The New England Journal of Medicine|September 26, 2003
Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosisPhilip S Wells, David R Anderson, Marc Rodger, et al.
Thrombosis and Haemostasis|February 22, 2023
Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation StudyMichelle Pradier, Marc A Rodger, Waleed Ghanima, et al.
Pageof 16

Showing results (71-80 of 152) with videos related to

Sort By:
Pageof 16
Annals of Internal Medicine|May 19, 2010
The vexing problem of guidelines and conflict of interest: a potential solutionGordon Guyatt, Elie A Akl, Jack Hirsh, et al.
The American Journal of Emergency Medicine|August 6, 2018
Comparison of the age-adjusted and clinical probability-adjusted D-dimer to exclude pulmonary embolism in the EDSameer Sharif, Michelle Eventov, Clive Kearon, et al.
Journal of Thrombosis and Haemostasis : JTH|September 26, 2021
Statins for venous event reduction in patients with venous thromboembolism: A multicenter randomized controlled pilot trial assessing feasibilityAurélien Delluc, Waleed Ghanima, Michael J Kovacs, et al.
The Lancet. Neurology|August 18, 2006
Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational studyMartin O'Donnell, Wes Oczkowski, Jiming Fang, et al.
Thrombosis Research|March 28, 2022
Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER)Aurélien Delluc, Waleed Ghanima, Michael J Kovacs, et al.
The New England Journal of Medicine|February 22, 2013
Extended use of dabigatran, warfarin, or placebo in venous thromboembolismSam Schulman, Clive Kearon, Ajay K Kakkar, et al.
Thrombosis and Haemostasis|September 26, 2015
Bleeding events with dabigatran or warfarin in patients with venous thromboembolismAmmar Majeed, Samuel Z Goldhaber, Ajay Kakkar, et al.
Chest|July 14, 2009
Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolismFrancis Couturaud, Christophe Leroyer, Jim A Julian, et al.
The New England Journal of Medicine|September 26, 2003
Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosisPhilip S Wells, David R Anderson, Marc Rodger, et al.
Thrombosis and Haemostasis|February 22, 2023
Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation StudyMichelle Pradier, Marc A Rodger, Waleed Ghanima, et al.
Pageof 16